期刊文献+

乳腺癌与甲状腺疾病相关性的临床研究 被引量:7

Clinical research on the relationship between breast cancer and thyroid disorder
原文传递
导出
摘要 目的探讨乳腺癌患者自身免疫与非自身免疫甲状腺疾病的发病情况。方法选择100例乳腺癌手术患者,以同期相对应年龄无乳腺疾病及甲状腺疾病病史女性100名为对照组,通过临床检查、B型超声、甲状腺素及抗体水平检查、细针穿刺活组织检查等对比甲状腺疾病的发病情况。结果乳腺癌患者抗甲状腺过氧化物酶抗体明显高于对照组[(104.56±21.54)U/ml比(22.16±4.65)u/ml,P=0.030]。乳腺癌组自身免疫与非自身免疫甲状腺疾病的发病率高于对照组[38%(38/100)比17%(17/100),P=0.0009;26%(26/100)与9%(9/100),P=0.0016]。结论乳腺癌患者的自身免疫与非自身免疫甲状腺疾病的发病率高于非乳腺癌者。 Objective To investigate the incidence of autoimmune and nonautoimmune thyroid diseases in patients with breast cancer. Methods Clinical and ultrasound evaluation of thyroid gland, detection of serum thyroid hormone and related antibodies, and fine-needle aspiration of thyroid gland were performed in 100 breast cancer patients and 100 control individuals during the period from 2004 to 2008. Results The mean values of anti-thyroid peroxidase antibodies were significantly higher in breast cancer patients than that in control individuals [(104.56±21.54) U/ml vs (22.16±4.65) U/ml, (P= 0.030)]. The incidence rates of autoimmune and nonautoimmune thyroid diseases were higher in breast cancer patients than that in control individuals [38 % (38/100) vs 17 % (17/100), P = 0.0009, 26 % (26/100) vs 9 % (9/100), P = 0.0016, respectively]. Conclusion The results indicate an increased incidence of autoimmnne and nonautoimmune thyroid diseases in breast cancer patients.
出处 《肿瘤研究与临床》 CAS 2013年第3期178-180,共3页 Cancer Research and Clinic
关键词 乳腺肿瘤 甲状腺疾病 Breast neoplasms Thyroid diseases
  • 相关文献

参考文献13

  • 1韩俊庆,俞新爽,刘奇.甲状腺疾病与乳腺癌的关系[J].实用肿瘤学杂志,2008,22(1):63-65. 被引量:18
  • 2Smyth PPA, Kilbane MT, Murray M J, et al. Serum lhyroid peroxidase autoantibodies,thyroid volume and outcome in breasl cancer. Clin Endocr Metab 1988, 83:2711-2716.
  • 3Parkin DN, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55: 742-108.
  • 4Giani C, Fierabracci P, Bonacei R, et al. Relalionship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breasl malignancy. J Endocr Metab, 1986, 81: 990-994.
  • 5赵二保,李剑,薛登峰.青年女性乳腺癌172例临床分析[J].肿瘤研究与临床,2011,23(9):631-632. 被引量:1
  • 6Mittra I, Perrin J, Kumaoka S. Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. BMJ, 1976, 1: 257-259.
  • 7Smyth PPA. Autoimmune thyroid disease and breas! eancer: a ehanee assaeiation. J Endoerinol Invest, 2000, 23: 42-43.
  • 8Dumont JE, Maenhaut C, Pirson I, et al. Growth factors enntrolling the thyroid gland. Baillieres Clin gndoerinol Meta, 1991,5: 727-754.
  • 9Spitzweg C, Joba W, Eisenmenger W, et al. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonu-cleic aeids from salivary gland, mammary gland and gastric muensa. J Clin Endoc Metab, 1998. 83: 1746-1751.
  • 10Kilbane MT, Shering SG, Symith DF, et al. Thyroid peroxidase (TPO): an autoanti-gen common to the thyroid and breast. J Endoc. 1998, 156: 323.

二级参考文献71

  • 1毕慧英,刘占凤.应用临床路径对乳腺癌患者的健康教育[J].中国误诊学杂志,2009,9(2):275-276. 被引量:3
  • 2施华.乳腺癌激素受体检测及其临床意义[J].中国综合临床,2004,20(9):860-861. 被引量:10
  • 3蔡方,赵勇.甲状腺激素与乳腺癌[J].医师进修杂志,1994,17(11):38-40. 被引量:3
  • 4李成贻,曹明智,孔滨,刘妮.41例青年乳腺癌ER、PR、CerbB-2、PCNA表达及其临床特征[J].现代中西医结合杂志,2007,16(3):309-310. 被引量:12
  • 5罗学林.乳腺癌与甲状腺激素[J].国外医学:肿瘤学分册,1981,8(5):213-214.
  • 6Arpino G,Weiss H,Lee AV,et al.Estrogen receptor-positive,progesterone receptor-negative breast cancer:association with growth factor receptor expression and tamoxifen resistance.J Natl Cancer Inst,2005,97:1254-1261.
  • 7Nilsson S,Makela S,Treuter E,et al.Mechanisms of estrogen action.Physiol Rev,2001,81:1535-1565.
  • 8Fox EM,Davis RJ,Shupnik MA.ERbeta in breast cancer-onlooker,passive player,or active protector? Steroids,2008,73:1039-1051.
  • 9Ricketts D,Turnbull L,Ryall G,et al.Estrogen and progesterone receptors in the normal female breast.Cancer Res,1991,51:1817-1822.
  • 10Markopoulos C,Berger U,Wilson P,et al.Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle.Br Med J (Clin Res Ed),1988,296:1349-1351.

共引文献18

同被引文献91

  • 1程维刚,殷德涛,卢秀波,邱新光,王庆兆.雌激素受体和细胞增殖周期调控蛋白D1在分化型甲状腺癌中的表达及意义[J].中国癌症杂志,2005,15(2):123-125. 被引量:17
  • 2沈美萍,侯大卫,刘翠萍,武正炎.雌二醇促进甲状腺乳头状癌细胞生长[J].南京医科大学学报(自然科学版),2006,26(9):853-856. 被引量:11
  • 3周军,王言理,韦玉芳.原发性肝癌患者手术前后血清T_3、T_4、FT_3、FT_4、rT_3、sTSH检测的临床意义[J].放射免疫学杂志,2007,20(6):498-499. 被引量:5
  • 4Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is as- sociated with breast cancer: a meta- analysis [ J~. Breast Cancer Res Treat, 2012,133(3) :1169 - 1177.
  • 5Turken O, NarIn Y, DemIrbas S, et al. Breast cancer in association with thyroid disorders[J]. Breast Cancer Res, 2003,60(5) : Rll0 - Rl13.
  • 6Puzianowska - Kuznicka M, Nauman A, Madej A, et al. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcino- ma[ J]. Cancer Lett, 2000,155 ( 1 ) : 145 - 152.
  • 7张学登,张翠萍,曲鲁平,等.恶性肿瘤患者甲状腺激素变化及其临床意义[J].中国肿瘤临床,2003,20(11):842.
  • 8Gonz61ez - Sancho JM, Figueroa A, L6pez - Barahona M, et al. Inhibi- tion of proliferation and expression of T1 and cyclin D 1 genes by thyroid hormone in manmary epithelial cells[ J]. Mol Carcinog, 2002,34 (1) : 25 - 34.
  • 9Dinda S, Sanchez A, Moudgil V. Estrogen - like effects of thyroid hor- mone on the regulation of tumor suppressor proteins, p53 and retinoblas- toma, in breast cancer cells [ J ]. Oncongene, 2002,21 (5) :761 - 768.
  • 10Gonz61ez - Sancho JM, Alvarez - Dolado M, Caelles C, et al. Inhibi- tion of tenascin - C expression in mammary epithelial ceils by thyroid hormone[ J]. Mol Careinog, 2000,24 (2) :99 - 107.

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部